Paul Tabor

Paul Tabor is a seasoned professional in technology commercialization and market research, currently serving as a Senior Associate at Oberland Capital since November 2021. Prior to this, Tabor held various roles at CU Innovations, Anschutz Medical Campus, including Director of Strategy and Associate Director, managing a diverse caseload of over 400 technologies. Valuable experience includes roles in market research at Pharmaceutical Market Insights and editing earnings reports at FactSet CallStreet. Tabor began the career as a Research Technician at the Human Genome Sequencing Center, contributing to major genomic projects. Educational qualifications include an MBA in Finance from Texas McCombs School of Business and advanced degrees in Clinical Gerontology and Chemistry and Biology from Baylor University.